Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine and Azithromycin for Malaria Prophylaxis
NCT03278808Phase 2Withdrawn
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of azithromycin in malaria (2 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Proportion of subjects free from symptomatic parasitemic subjects. Planned start Sep 2018; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03278808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03278808.